AI-generated summary
The authors report a prospective safety study of 25 postmenopausal women with vaginal atrophy-related pelvic pain who received six weekly photobiomodulation sessions with a vaginal probe. Most of the 148 adverse events were minor, mainly heat sensation, and pain during intercourse and vaginal health scores improved. The authors note that the study was preliminary and that efficacy requires a randomized trial.
- Participants
- 25
- Who or what was studied
- Postmenopausal women with genitourinary syndrome of menopause and pelvic pain after failure of non-invasive therapies for more than 3 months
- Limits stated in the abstract
- The abstract describes a preliminary, first-in-human study without a control group, and efficacy was not assessed in a randomized trial.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Primary outcome, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.